相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning
Vittorio Martinelli et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning
Vittorio Martinelli et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Therapeutic use of CCR5 antagonists is supported by strong expression of CCR5 on CD8+ T cells in progressive multifocal leukoencephalopathy-associated immune reconstitution inflammatory syndrome
Guillaume Martin-Blondel et al.
ACTA NEUROPATHOLOGICA (2015)
Melanoma cell adhesion molecule-positive CD8 T lymphocytes mediate central nervous system inflammation
Catherine Larochelle et al.
ANNALS OF NEUROLOGY (2015)
Clinical and radiologic rebound after discontinuation of natalizumab therapy in a highly active multiple sclerosis patient was not halted by dimethyl-fumarate: a case report
Francesco Patti et al.
BMC NEUROLOGY (2015)
Massive exacerbation of multiple sclerosis after withdrawal and early restart of treatment with natalizumab
Lena-Alexandra Beume et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
Switching from natalizumab to fingolimod A randomized, placebo-controlled study in RRMS
Ludwig Kappos et al.
NEUROLOGY (2015)
Update on treatments in multiple sclerosis
Laure Michel et al.
PRESSE MEDICALE (2015)
Intense immunosuppression for the treatment of an immune reconstitution inflammatory syndrome-like exacerbation after natalizumab withdrawal: a case report
Maria Sepulveda et al.
JOURNAL OF NEUROLOGY (2015)
Significant clinical worsening after natalizumab withdrawal: Predictive factors
A. Vidal-Jordana et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Central role of Th2/Tc2 lymphocytes in pattern II multiple sclerosis lesions
Raquel Planas et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers
Marianna Lo Re et al.
NEUROLOGY AND THERAPY (2015)
Immunological effects of methylprednisolone pulse treatment in progressive multiple sclerosis
R. Ratzer et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients
Per Soelberg Sorensen et al.
JOURNAL OF NEUROLOGY (2014)
Abnormal inflammatory activity returns after natalizumab cessation in multiple sclerosis
Antoine Gueguen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Fingolimod after natalizumab and the risk of short-term relapse
Vilija G. Jokubaitis et al.
NEUROLOGY (2014)
MS disease activity in RESTORE A randomized 24-week natalizumab treatment interruption study
Robert J. Fox et al.
NEUROLOGY (2014)
Maraviroc and JC Virus-Associated Immune Reconstitution Inflammatory Syndrome
Paul S. Giacomini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Switching From Natalizumab to Fingolimod in Multiple Sclerosis A French Prospective Study
Mikael Cohen et al.
JAMA NEUROLOGY (2014)
Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy
Imke Metz et al.
ACTA NEUROPATHOLOGICA (2012)
Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system
Catherine Larochelle et al.
BRAIN (2012)
Expression of CCR7 and CD45RA in CD4+ and CD8+ subsets in cerebrospinal fluid of 134 patients with inflammatory and non-inflammatory neurological diseases
Katherine M. Mullen et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
LETHAL MULTIPLE SCLEROSIS RELAPSE AFTER NATALIZUMAB WITHDRAWAL
Valerie Rigau et al.
NEUROLOGY (2012)
CD161highCD8+T cells bear pathogenetic potential in multiple sclerosis
Viviana Annibali et al.
BRAIN (2011)
How do immune cells overcome the blood-brain barrier in multiple sclerosis?
Catherine Larochelle et al.
FEBS LETTERS (2011)
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME AFTER WITHDRAWAL OF NATALIZUMAB?
T. Lenhard et al.
NEUROLOGY (2010)
Preferential Recruitment of Interferon-γ-Expressing TH17 Cells in Multiple Sclerosis
Hania Kebir et al.
ANNALS OF NEUROLOGY (2009)
C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE
Andrea Reboldi et al.
NATURE IMMUNOLOGY (2009)
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis
John S. Tzartos et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
The activation of memory CD4+ T cells and CD8+ T cells in patients with multiple sclerosis
Y Okuda et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation:: implications for CNS trafficking
P Kivisäkk et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects
EM Martinez-Caceres et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
分享论文
